Arvaya Healthcare Share Price Today

Arvaya Healthcare committee approves rights issue draft offer

Rights Issue Committee approved Draft Letter of Offer for up to ₹20,580.00 lakhs. Issue involves partly paid-up equity shares with face value of ₹10 each. Filing with BSE and application for in-principle approval authorised. Follows board’s November 4 revision delegating authority to the Committee.

Arvaya Healthcare completes acquisition of Sushodha Institute

Arvaya Healthcare acquired 1,84,374 equity shares in Sushodha Institute. The purchase represents 100% of SIGPL's equity share capital. Acquisition completed on November 1, 2026, making SIGPL a wholly owned subsidiary.

Arvaya Healthcare director acquires 591,129 shares via preferential allotment

Bidari Kotresh Anilkumar acquired 591,129 equity shares on October 24, 2026. Stake increased from 3.58% to 4.45% following preferential allotment. Disclosure filed under SEBI (Prohibition of Insider Trading) Regulations, 2015.

Arvaya Healthcare allots 38.7 lakh shares at ₹40 to SIGPL shareholders

Arvaya Healthcare allotted 38,71,854 equity shares to SIGPL shareholders via share swap. Issue price set at ₹40 per share, comprising ₹10 face value and ₹30 premium. Paid-up capital increases to ₹51.89 crore from ₹48.02 crore post-allotment. Transaction valued at ₹15.49 crore, approved by BSE on October 12, 2026. New shares rank pari-passu with existing equity and are subject to lock-in.

Arvaya Healthcare 41st AGM passes all five resolutions unanimously

All five resolutions at Arvaya Healthcare's 41st AGM on September 21, 2026 were passed as ordinary resolutions with requisite majority. Resolutions 1-3 received 32,807,821 votes in favour (100% of valid votes polled), representing 68.32% of total outstanding shares. Resolutions 4 and 5 on material related-party transactions and IP acquisition received 16,383,269 valid votes in favour (100%), with promoter group abstaining as interested parties. Key approvals include acquisition of the copyright and IP portfolio of DEFIB Institute of Health Solutions LLP, funded from rights issue proceeds. Strategic updates include re-branding to Arvaya Healthcare, incorporation of Arvaya Insurance Broking Private Limited as a wholly owned subsidiary, and ongoing acquisition of Sushoda Institute of Gastroenterology Private Limited.

Arvaya Healthcare AGM to approve ₹390 crore related party transactions

Arvaya Healthcare AGM scheduled for September 21, 2026, via video conference. Shareholders to approve ₹390 crore in related party transactions for FY27. Reappointment of Managing Director Kaushal Uttam Shah on agenda. E-voting period set for September 18-20, 2026.